HERZLIYA, Israel, August 6, 2015 /PRNewswire/ --
Impact First Investments (IFI), Israel's leading impact investment firm, announced today that Dr. Amir Lerman, Professor of Medicine and the Mayo Clinic, has joined its advisory committee.
Dr. Lerman serves as an associate chair and director of research for the cardiovascular division and the director of the Mayo cardiovascular research center. Dr. Lerman is considered a world leader in coronary physiology and imaging, regenerative medicine and digital health.
Impact First Investments is the first and largest Israeli investment firm specifically designed to leverage local technology and innovation to create global social impact. By exclusively investing in socially driven Israeli start-ups, the firm is uniquely positioned at the crossroads between global social challenges and the technological solutions that address them.
IFI's advisory board already counts leaders in venture capital, technology and social responsibility among its members, including Chemi Peres, IFI Advisory Committee Chair and Managing General Partner and Co-Founder of Pitango Venture Capital; Rami Kalish, chairman of the investment committee at IFI and Managing General Partner and Co-Founder at Pitango Venture Capital; Dr. Yoav Ben Dror, founding Partner at IFI and of Israel's most successful investors; Dana Porter Rubinsthein, head of Business Strategy, Marketing and Planning for the Microsoft Israel Research & Development Center and; Tomer Kalkstein Loubaton, an investor and investor representative in technological businesses at IFI and the former CEO of Snir, an Israeli non-profit organization providing disadvantaged children with equal opportunities in education and culture.
"Impact First Investments is an ideal place to pursue my passion of advancing technology to benefit the greater good," said Dr. Lerman, "I am honored to have been selected to serve on their advisory committee and to join one of the most forward thinking investment funds in the world."
"We are thrilled that Dr. Lerman will be joining our team," said Cecile Blilious, Managing Director of IFI. "He is a world renowned leader in high-tech medical research and will be a strong asset for us moving forward, as we continue to add Israeli medical technology startups to our portfolio."
About Impact First Investments:
Impact First Investments is the first Israeli investment firm specifically designed to leverage local technology and innovation to create global social impact. By exclusively investing in socially driven Israeli start-ups, the firm is uniquely positioned at the crossroads between global social challenges and the technological solutions that address them. In recent years, Israel has claimed its role as a high tech "powerhouse", commonly referred to as "the Start-up Nation", and as such, has successfully enhanced the lives of individuals and communities around the globe through its innovation and robust tech industry. Impact First is seeking to leverage Israel's unique aptitude for tech innovation, and the growing global interest in the impact investment market, to create sustainable global social impact.
GKPR for Impact First Investments
SOURCE Impact First Investments (IFI)